O’Melveny has advised TransThera Sciences (Nanjing), Inc. Sidley has advised joint sponsors CITIC Securities (Hong Kong) Limited and Huatai...
Vous n'êtes pas connecté
Rubriques :
- HARNEYS.COM - A La Une - 07/Jul 08:55
Harneys advises Cloudbreak Pharma Inc. on its Hong Kong IPO
Harneys acted as Cayman Islands counsel on the global offering of shares by Cloudbreak Pharma Inc., facilitating its successful listing on The Stock Exchange of Hong Kong Limited. The shares began trading on HKEx on 3 July 2025, raising approximately HK$611 million.
Articles similaires
TransThera Sciences Completes HK$200 Million H-Share IPO on Hong Kong Exchange
globallegalchronicle.com - 22/Jul 00:00
O’Melveny has advised TransThera Sciences (Nanjing), Inc. Sidley has advised joint sponsors CITIC Securities (Hong Kong) Limited and Huatai...
Hong Kong, mainland stocks muted
wn.com - 16/Jul 09:57
Hong Kong shares ended its four-day rally to dip 0.3 percent on Wednesday....
Hong Kong, mainland stocks muted
wn.com - 16/Jul 09:57
Hong Kong shares ended its four-day rally to dip 0.3 percent on Wednesday....
European Commission Updates AML/CTF List: Cayman Islands to be removed
harneys.com - 11/Jul 12:35
On 12 December 2023, the European Commission published an amendment to Delegated Regulation (EU) 2016/1675 which will have the effect of removing the...
Henderson Land Issues Record HK$8bn Convertible Bonds in Hong Kong Property Sector
globallegalchronicle.com - 21/Jul 00:00
Slaughter and May advised Henderson Land Development Company Limited; Linklaters acted for HSBC as the sole global coordinator. Henderson Land...
Africa’s phone king eyes $1-billion Hong Kong listing
techcentral.co.za - 21/Jul 12:17
The biggest seller of mobile phones in Africa is weighing a listing in Hong Kong that could raise up to $1-billion.
Africa’s phone king eyes $1-billion Hong Kong listing
techcentral.co.za - 21/Jul 12:17
The biggest seller of mobile phones in Africa is weighing a listing in Hong Kong that could raise up to $1-billion.
Cloudbreak Pharma Inc. Announces Positive Phase 2 Results for CBT-004 in Patients with Vascularized Pinguecula
financialpost.com - 21/Jul 00:32
Novel preservative-free CBT-004 eye drop formulation demonstrates statistically significant improvements in conjunctival hyperemia and...
Cloudbreak Pharma Inc. Announces Positive Phase 2 Results for CBT-004 in Patients with Vascularized Pinguecula
financialpost.com - 21/Jul 00:32
Novel preservative-free CBT-004 eye drop formulation demonstrates statistically significant improvements in conjunctival hyperemia and...
Les derniers communiqués
-
Aucun élément